Prograf Tacrolimus 0.5 mg

Prograf is a prescription immunosuppressant medication containing the active ingredient tacrolimus, primarily used to prevent organ rejection in patients who have received kidney, liver, or heart transplants. It was originally developed in Japan by Fujisawa Pharmaceutical Co., Ltd. following the discovery of tacrolimus from a soil sample found in Tsukuba.

Today, Prograf is a flagship product of Astellas Pharma, which was formed through the merger of Fujisawa and Yamanouchi Pharmaceutical. While the brand is of Japanese origin, manufacturing occurs globally across various specialized pharmaceutical facilities to serve international markets. The product shown in the image is typically distributed in regions like Australia or Europe, as indicated by the specific packaging format and dosage instructions.